Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. [PDF]
Böhm M+15 more
europepmc +1 more source
Focusing on microvascular function in heart failure with preserved ejection fraction. [PDF]
Velollari O+4 more
europepmc +1 more source
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction. [PDF]
Mourmans SGJ+13 more
europepmc +1 more source
Examination of the Suitability of Vericiguat in Non-Heart Failure with Preserved Ejection Fraction Patients with Improved Ejection Fraction. [PDF]
Kinoshita H+12 more
europepmc +1 more source
Author Correction: External validation of artificial intelligence for detection of heart failure with preserved ejection fraction. [PDF]
Akerman AP+13 more
europepmc +1 more source
Mib2 Regulates Lipid Metabolism in Heart Failure With Preserved Ejection Fraction via the Runx2-Hmgcs2 Axis. [PDF]
Cai Z, Xu S, Xiao X, Liu C, Zu L.
europepmc +1 more source
"Better Is the Enemy of Good": The Deleterious Effects of Supra-Normal Left Ventricular Ejection Fraction. [PDF]
Dorobanțu M, Vîjîiac A.
europepmc +1 more source